Amazon just transformed your doctor’s waiting room into a pharmacy, and the weight loss drug revolution will never be the same.
Story Snapshot
- Amazon One Medical kiosks in California now dispense GLP-1 weight loss pills including Foundayo and Wegovy immediately after consultation
- Patients receive prescriptions via QR code and pick up medications on-site, eliminating delivery wait times and fees
- Foundayo costs $149 monthly without insurance, drastically undercutting traditional injectable GLP-1 medications that exceed $1,000 monthly
- Five Los Angeles area locations launched in December 2025 with nationwide expansion talks underway for 2026
- The initiative addresses critical shortages in popular diabetes and weight loss drugs like Ozempic and Wegovy
The Pharmacy Counter Meets the App Store
Amazon installed prescription medication kiosks inside five One Medical clinics across greater Los Angeles, creating an unprecedented point-of-care pharmacy experience. Patients consult healthcare providers, receive prescriptions through the Amazon app, scan a QR code at the kiosk, and walk out with their medication.
The December 2025 launch targets locations in Downtown Los Angeles, West Los Angeles, Beverly Hills, Long Beach, and West Hollywood. Amazon Pharmacy Vice President Hannah McClellan Richards confirmed plans to expand beyond California in 2026 through partnerships with external health systems.
What Americans Actually Get at These Kiosks
The kiosks stock Eli Lilly’s Foundayo, an FDA-approved oral GLP-1 medication for weight loss, alongside Wegovy pills from competitor Novo Nordisk. Foundayo entered kiosks in early 2026 after Wegovy pills arrived in January 2025. Amazon Pharmacy verifies each prescription and curates inventory based on location demand.
Insurance and Amazon Prime memberships unlock discounts, though the curated selection means not every prescription reaches kiosks. Amazon Pharmacy separately fulfills injectable Ozempic through standard delivery channels, not kiosks, because no FDA-approved Ozempic pill exists despite widespread market confusion.
Amazon to carry Ozempic pill at U.S. kiosks, offer same-day delivery https://t.co/NCsyXNo2fO
— CNBC (@CNBC) May 7, 2026
The Billion Dollar Obesity Battle Amazon Just Entered
GLP-1 receptor agonists exploded into a projected $100 billion market by 2030, driven by America’s 42 percent adult obesity rate and chronic shortages of injectable medications. Amazon acquired One Medical for $3.9 billion in 2023, integrating telehealth with its 2020-launched Amazon Pharmacy to create this kiosk model.
Eli Lilly introduced LillyDirect in 2023 for direct-to-consumer GLP-1 access, and Amazon Pharmacy now fulfills those prescriptions. The FDA declared shortages for Ozempic and Wegovy between 2022 and 2025, pushing pharmaceutical companies toward oral alternatives that eliminate injection barriers and manufacturing bottlenecks.
Why Traditional Pharmacies Should Be Terrified
Amazon’s same-day kiosk model eliminates the three pain points killing traditional pharmacies: wait times, delivery fees, and prescription abandonment. Patients leaving appointments without starting treatment costs the healthcare system billions annually. Amazon pharmacists review prescriptions remotely while patients remain on-site, compressing the fulfillment cycle from days to minutes.
The California pilot positions Amazon to pressure chains like CVS by bundling pharmacy access with Prime membership perks and One Medical subscriptions ranging from $99 to $199 annually. Industry analysts call this point-of-care integration a dramatic access improvement, though equity concerns linger since California exclusivity leaves 49 states waiting.
The expansion hinges on Amazon convincing external health systems to install kiosks, a prospect requiring infrastructure investment and competitive negotiation. Pharmacy leaders praise the innovation while warning about inventory limitations and over-reliance on Big Tech controlling healthcare access.
The regulatory environment poses questions too, given direct-to-consumer prescription models faced scrutiny during the opioid crisis.
Amazon’s logistics prowess meets pharmaceutical regulation in uncharted territory, with potential overprescription and side effect management creating liability exposure.
The convenience calculus makes sense for patients desperate for affordable GLP-1 access, but centralizing prescription fulfillment through a retail giant concentrates power in ways policymakers haven’t fully addressed.
Sources:
Healthline – Amazon GLP-1 Pill Foundayo Kiosks Same-Day Delivery
About Amazon – Amazon Pharmacy Kiosks One Medical
Amazon Pharmacy – Ozempic Injectable Product Page
